Join us live for this exciting multi-city broadcast event, where Dr. Vipul Jairath, Dr. John Marshall and Dr. Mark Silverberg will discuss NEW data on the use of IL-23 inhibitors in the treatment of ulcerative colitis. Register below!

VIRTUAL EVENT

September 28, 2023
7:30 - 8:30 PM, Eastern Time
Thursday
September 28, 2023
7:30 pm - 8:30 pm EST

SPEAKERS


John MarshallMD, MSc, FRCPC, CAGF, AGAF
Professor of Medicine
Director, Division of
Gastroenterology
McMaster University
Hamilton (ON)
Show Bio

Mark SilverbergMD, PhD, FRCPC
Professor of Medicine, Division of Gastroenterology, University of Toronto
Director, Toronto Immune and Digestive
Health Institute
Toronto (ON)
Show Bio

MODERATOR


Vipul JairathMBChB, DPhil
Professor of Medicine,
Departments of Medicine, Epidemiology and Biostatistics John and Susan McDonald Endowed Chair in IBD Clinical Research
Director, Advanced IBD Fellowship Program Associate Chair (Research), Department of Medicine Schulich School of Medicine & Dentistry, Western University
University London (ON)
Show Bio

LEARNING OBJECTIVES


At the conclusion of this program, participants should be better able to:
  • Explain the mechanism of action of IL-23p19 inhibitors for ulcerative colitis and how this is different from other approved advanced therapies
  • Describe the clinical trial evidence of efficacy and safety with the IL-23p19 inhibitors approved—or under development for—the treatment of ulcerative colitis
  • Identify patients with ulcerative colitis who would benefit from the use of IL-23p19 inhibitors for induction and/or maintenance treatment

Please enter your information below to register for this virtual event








Please bring your own device to participate in the interactive portion of this program